AbbVie's $46.5 Billion Bid for Shire Rejected

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

June 20 (Bloomberg) -- AbbVie Inc., the U.S. drugmaker split last year from Abbott Laboratories, said three escalating offers to buy Shire Plc for as much as 27.3 billion pounds ($46.5 billion) were rejected by the Dublin-based company. Matt Campbell reports on Bloomberg Television's "On the Move" with Anna Edwards. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change